Caladrius Biosciences Inc., a clinical-stage biopharmaceutical company based in Basking Ridge, has been on the hunt for “strategic development opportunities” this past year, according to President and ...
On Wednesday, shares of clinical-stage biopharmaceutical company Caladrius Biosciences (CLBS) took off by a whopping 110%. However, the surge did not come off the back of a treatment’s regulatory ...
Caladrius Blaze features not only the Shame Break system where you can view fantastic eye-candy cut-in graphics for both the playable characters and the bosses as they take damage and clothes are cut ...
Combined company to be renamed Lisata Therapeutics upon transaction closing Combination will create a financially sound Nasdaq-listed company with a diverse product development pipeline, strong ...
Moss, known for developing the Raiden series, explained the Element Shoot system for their upcoming shoot ‘em up, Caladrius. The Element Shoot is a special attack that makes each character in ...
BASKING RIDGE, N.J., July 07, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and ...
As Caladrius Biosciences merges with Cend Therapeutics to become Lisata Therapeutics, it’s leaving a coronary artery disease trial by the wayside. The biotech announced plans to shelve, at least for ...
BASKING RIDGE, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the ...
Initiation of the Phase 2b FREEDOM trial represents the next step in development of CLBS16 as a potential breakthrough treatment for the millions of sufferers of CMD in the U.S., most of whom are ...
BASKING RIDGE, N.J., March 08, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the ...
Caladrius reported in May 2020 the compelling positive results of its ESCaPE-CMD Phase 2a study of CLBS16 for the treatment of coronary microvascular dysfunction (“CMD”), a disease that continues to ...
Basking Ridge-based Caladrius Biosciences, a clinical-stage biopharmaceutical company that focuses on the development of cellular therapies designed to reverse, not manage disease, recently said the U ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback